Next 3 - 12 months would make or break prr. Positive outcomes which would potential see the sp get close its 10-yr highs & maybe beyond:
1) ODS approval from US FDA - significantly milestone
2) Significant positive update on PIIb/III trials
3) Approval or consideration for CVac approval in jurisdictions other than the US
4) Major re-rating
5) Partnership from big pharmas
Pontential PRR breakers/set backs would be the opposite of above esp. (1) to (3). (1) & (2) would trigger largely be responsible for(4) & (5) to occur.
The risks are currently still high but not as high as say 6 months ago. If, say, 1, (2) & (3) are achieved; risk would significantly be lower than current. This would be reflected in the sp.
next 3 - 6 months
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |